FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070577009> ?p ?o ?g. }

• W2070577009 endingPage "691" @default.
• W2070577009 startingPage "685" @default.
• W2070577009 abstract "We previously have described a group of patients with gluten sensitivity presenting with ataxia (gluten ataxia) and suggested that this disease entity may account for a large number of patients with sporadic idiopathic ataxia. We have therefore investigated the prevalence of gluten sensitivity amongst a large cohort of patients with sporadic and familial ataxia and looked at possible genetic predisposition to gluten sensitivity amongst these groups. Two hundred and twenty-four patients with various causes of ataxia from North Trent (59 familial and/or positive testing for spinocerebellar ataxias 1, 2, 3, 6 and 7, and Friedreich's ataxia, 132 sporadic idiopathic and 33 clinically probable cerebellar variant of multiple system atrophy MSA-C) and 44 patients with sporadic idiopathic ataxia from The Institute of Neurology, London, were screened for the presence of antigliadin antibodies. A total of 1200 volunteers were screened as normal controls. The prevalence of antigliadin antibodies in the familial group was eight out of 59 (14%), 54 out of 132 (41%) in the sporadic idiopathic group, five out of 33 (15%) in the MSA-C group and 149 out of 1200 (12%) in the normal controls. The prevalence in the sporadic idiopathic group from London was 14 out of 44 (32%). The difference in prevalence between the idiopathic sporadic groups and the other groups was highly significant (P < 0.0001 and P < 0.003, respectively). The clinical characteristics of 68 patients with gluten ataxia were as follows: the mean age at onset of the ataxia was 48 years (range 14-81 years) with a mean duration of the ataxia of 9.7 years (range 1-40 years). Ocular signs were observed in 84% and dysarthria in 66%. Upper limb ataxia was evident in 75%, lower limb ataxia in 90% and gait ataxia in 100% of patients. Gastrointestinal symptoms were present in only 13%. MRI revealed atrophy of the cerebellum in 79% and white matter hyperintensities in 19%. Forty-five percent of patients had neurophysiological evidence of a sensorimotor axonal neuropathy. Gluten-sensitive enteropathy was found in 24%. HLA DQ2 was present in 72% of patients. Gluten ataxia is therefore the single most common cause of sporadic idiopathic ataxia. Antigliadin antibody testing is essential at first presentation of patients with sporadic ataxia." @default.
• W2070577009 created "2016-06-24" @default.
• W2070577009 creator A5000364062 @default.
• W2070577009 creator A5006490260 @default.
• W2070577009 creator A5008823861 @default.
• W2070577009 creator A5012681032 @default.
• W2070577009 creator A5034555216 @default.
• W2070577009 creator A5037195356 @default.
• W2070577009 creator A5052368933 @default.
• W2070577009 creator A5062779449 @default.
• W2070577009 creator A5081394869 @default.
• W2070577009 date "2003-03-01" @default.
• W2070577009 modified "2023-10-12" @default.
• W2070577009 title "Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics" @default.
• W2070577009 cites W1592243647 @default.
• W2070577009 cites W1950778173 @default.
• W2070577009 cites W1991013976 @default.
• W2070577009 cites W2022798820 @default.
• W2070577009 cites W2025450230 @default.
• W2070577009 cites W2034280164 @default.
• W2070577009 cites W2042846725 @default.
• W2070577009 cites W2050590860 @default.
• W2070577009 cites W2065057152 @default.
• W2070577009 cites W2082852953 @default.
• W2070577009 cites W2088680533 @default.
• W2070577009 cites W2091518539 @default.
• W2070577009 cites W2099718281 @default.
• W2070577009 cites W2104086030 @default.
• W2070577009 cites W2110155360 @default.
• W2070577009 cites W2118812097 @default.
• W2070577009 cites W2164941466 @default.
• W2070577009 cites W2169033404 @default.
• W2070577009 cites W2112442563 @default.
• W2070577009 doi "https://doi.org/10.1093/brain/awg050" @default.
• W2070577009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12566288" @default.
• W2070577009 hasPublicationYear "2003" @default.
• W2070577009 type Work @default.
• W2070577009 sameAs 2070577009 @default.
• W2070577009 citedByCount "264" @default.
• W2070577009 countsByYear W20705770092012 @default.
• W2070577009 countsByYear W20705770092013 @default.
• W2070577009 countsByYear W20705770092014 @default.
• W2070577009 countsByYear W20705770092015 @default.
• W2070577009 countsByYear W20705770092016 @default.
• W2070577009 countsByYear W20705770092017 @default.
• W2070577009 countsByYear W20705770092018 @default.
• W2070577009 countsByYear W20705770092019 @default.
• W2070577009 countsByYear W20705770092020 @default.
• W2070577009 countsByYear W20705770092021 @default.
• W2070577009 countsByYear W20705770092022 @default.
• W2070577009 countsByYear W20705770092023 @default.
• W2070577009 crossrefType "journal-article" @default.
• W2070577009 hasAuthorship W2070577009A5000364062 @default.
• W2070577009 hasAuthorship W2070577009A5006490260 @default.
• W2070577009 hasAuthorship W2070577009A5008823861 @default.
• W2070577009 hasAuthorship W2070577009A5012681032 @default.
• W2070577009 hasAuthorship W2070577009A5034555216 @default.
• W2070577009 hasAuthorship W2070577009A5037195356 @default.
• W2070577009 hasAuthorship W2070577009A5052368933 @default.
• W2070577009 hasAuthorship W2070577009A5062779449 @default.
• W2070577009 hasAuthorship W2070577009A5081394869 @default.
• W2070577009 hasBestOaLocation W20705770091 @default.
• W2070577009 hasConcept C118552586 @default.
• W2070577009 hasConcept C126322002 @default.
• W2070577009 hasConcept C142724271 @default.
• W2070577009 hasConcept C16568411 @default.
• W2070577009 hasConcept C187212893 @default.
• W2070577009 hasConcept C2776336767 @default.
• W2070577009 hasConcept C2779500118 @default.
• W2070577009 hasConcept C2780906641 @default.
• W2070577009 hasConcept C71924100 @default.
• W2070577009 hasConcept C72563966 @default.
• W2070577009 hasConcept C90924648 @default.
• W2070577009 hasConceptScore W2070577009C118552586 @default.
• W2070577009 hasConceptScore W2070577009C126322002 @default.
• W2070577009 hasConceptScore W2070577009C142724271 @default.
• W2070577009 hasConceptScore W2070577009C16568411 @default.
• W2070577009 hasConceptScore W2070577009C187212893 @default.
• W2070577009 hasConceptScore W2070577009C2776336767 @default.
• W2070577009 hasConceptScore W2070577009C2779500118 @default.
• W2070577009 hasConceptScore W2070577009C2780906641 @default.
• W2070577009 hasConceptScore W2070577009C71924100 @default.
• W2070577009 hasConceptScore W2070577009C72563966 @default.
• W2070577009 hasConceptScore W2070577009C90924648 @default.
• W2070577009 hasIssue "3" @default.
• W2070577009 hasLocation W20705770091 @default.
• W2070577009 hasLocation W20705770092 @default.
• W2070577009 hasOpenAccess W2070577009 @default.
• W2070577009 hasPrimaryLocation W20705770091 @default.
• W2070577009 hasRelatedWork W2003553966 @default.
• W2070577009 hasRelatedWork W2603773853 @default.
• W2070577009 hasRelatedWork W2799794127 @default.
• W2070577009 hasRelatedWork W2898175946 @default.
• W2070577009 hasRelatedWork W2978378121 @default.
• W2070577009 hasRelatedWork W2989723240 @default.
• W2070577009 hasRelatedWork W4225639135 @default.
• W2070577009 hasRelatedWork W4379793450 @default.
• W2070577009 hasRelatedWork W4385798810 @default.

• next